These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27925290)

  • 1. Bisphosphonate Withdrawal: Effects on Bone Formation and Bone Resorption in Maturing Male Mice.
    Ko FC; Karim L; Brooks DJ; Bouxsein ML; Demay MB
    J Bone Miner Res; 2017 Apr; 32(4):814-820. PubMed ID: 27925290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologically Inactive Bisphosphonates as an Alternative Strategy for Targeting Osteoclasts: In Vivo Assessment of 5-Fluorodeoxyuridine-Alendronate in a Preclinical Model of Breast Cancer Bone Metastases.
    Schem C; Tower RJ; Kneissl P; Rambow AC; Campbell GM; Desel C; Damm T; Heilmann T; Fuchs S; Zuhayra M; Trauzold A; Glüer CC; Schott S; Tiwari S
    J Bone Miner Res; 2017 Mar; 32(3):536-548. PubMed ID: 27714838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bisphosphonates on the rapidly growing male murine skeleton.
    Zhu ED; Louis L; Brooks DJ; Bouxsein ML; Demay MB
    Endocrinology; 2014 Apr; 155(4):1188-96. PubMed ID: 24422540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
    Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
    Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.
    Coe LM; Tekalur SA; Shu Y; Baumann MJ; McCabe LR
    J Cell Physiol; 2015 Aug; 230(8):1944-53. PubMed ID: 25641511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient retention of endochondral cartilaginous matrix with bisphosphonate treatment in a long-term rabbit model of distraction osteogenesis.
    Smith EJ; McEvoy A; Little DG; Baldock PA; Eisman JA; Gardiner EM
    J Bone Miner Res; 2004 Oct; 19(10):1698-705. PubMed ID: 15355565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.
    Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S
    Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate modulates morphological and mechanical properties in distraction osteogenesis through inhibition of bone resorption.
    Takahashi M; Yukata K; Matsui Y; Abbaspour A; Takata S; Yasui N
    Bone; 2006 Sep; 39(3):573-81. PubMed ID: 16713413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates for prevention of postmenopausal osteoporosis.
    Ravn P
    Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent Parathyroid Hormone After Prolonged Alendronate Treatment Induces Substantial New Bone Formation and Increases Bone Tissue Heterogeneity in Ovariectomized Rats.
    Altman-Singles AR; Jeong Y; Tseng WJ; de Bakker CM; Zhao H; Lott C; Robberts J; Qin L; Han L; Kim DG; Liu XS
    J Bone Miner Res; 2017 Aug; 32(8):1703-1715. PubMed ID: 28467646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
    Ma YL; Bryant HU; Zeng Q; Schmidt A; Hoover J; Cole HW; Yao W; Jee WS; Sato M
    Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
    Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
    Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of bone resorption by bisphosphonates interferes with orthodontically induced midpalatal suture expansion in mice.
    Koehne T; Kahl-Nieke B; Amling M; Korbmacher-Steiner H
    Clin Oral Investig; 2018 Jul; 22(6):2345-2351. PubMed ID: 29344807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.
    Iwata K; Li J; Follet H; Phipps RJ; Burr DB
    Bone; 2006 Nov; 39(5):1053-1058. PubMed ID: 16807159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of alendronate on bone formation and resorption in a rat ectopic bone development model.
    Yaffe A; Kollerman R; Bahar H; Binderman I
    J Periodontol; 2003 Jan; 74(1):44-50. PubMed ID: 12593595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration.
    Miller PD; McCarthy EF
    Semin Arthritis Rheum; 2015 Apr; 44(5):477-482. PubMed ID: 25312241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats.
    Lauritzen DB; Balena R; Shea M; Seedor JG; Markatos A; Le HM; Toolan BC; Myers ER; Rodan GA; Hayes WC
    J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates Inhibit Pain, Bone Loss, and Inflammation in a Rat Tibia Fracture Model of Complex Regional Pain Syndrome.
    Wang L; Guo TZ; Hou S; Wei T; Li WW; Shi X; Clark JD; Kingery WS
    Anesth Analg; 2016 Oct; 123(4):1033-45. PubMed ID: 27636578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates impair the onset of bone formation at remodeling sites.
    Jensen PR; Andersen TL; Chavassieux P; Roux JP; Delaisse JM
    Bone; 2021 Apr; 145():115850. PubMed ID: 33465485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of drug discontinuation after short-term daily alendronate administration on osteoblasts and osteocytes in mice.
    Tsuboi K; Hasegawa T; Yamamoto T; Sasaki M; Hongo H; de Freitas PH; Shimizu T; Takahata M; Oda K; Michigami T; Li M; Kitagawa Y; Amizuka N
    Histochem Cell Biol; 2016 Sep; 146(3):337-50. PubMed ID: 27235014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.